Hugo A. Jørgensen

2.4k total citations
83 papers, 1.9k citations indexed

About

Hugo A. Jørgensen is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Hugo A. Jørgensen has authored 83 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Psychiatry and Mental health, 27 papers in Cellular and Molecular Neuroscience and 14 papers in Cognitive Neuroscience. Recurrent topics in Hugo A. Jørgensen's work include Schizophrenia research and treatment (37 papers), Neuroscience and Neuropharmacology Research (19 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Hugo A. Jørgensen is often cited by papers focused on Schizophrenia research and treatment (37 papers), Neuroscience and Neuropharmacology Research (19 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Hugo A. Jørgensen collaborates with scholars based in Norway, United States and Denmark. Hugo A. Jørgensen's co-authors include Ole A. Andreassen, Erik Johnsen, Rune A. Kroken, Kenneth Hugdahl, Tore Wentzel‐Larsen, Else‐Marie Løberg, Kjell Hole, Rolf Gjestad, Kjell Hole and Torleif Ruud and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain Research.

In The Last Decade

Hugo A. Jørgensen

81 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hugo A. Jørgensen Norway 25 828 492 385 263 248 83 1.9k
Eduard Parellada Spain 30 1.4k 1.7× 384 0.8× 478 1.2× 324 1.2× 184 0.7× 98 2.5k
Burt Angrist United States 23 1.2k 1.5× 765 1.6× 464 1.2× 309 1.2× 324 1.3× 61 2.2k
Suzanne Reeves United Kingdom 26 708 0.9× 319 0.6× 588 1.5× 168 0.6× 232 0.9× 81 1.9k
Nobuhisa Kanahara Japan 24 903 1.1× 562 1.1× 318 0.8× 414 1.6× 232 0.9× 94 2.0k
A. Klimke Germany 22 709 0.9× 286 0.6× 416 1.1× 174 0.7× 135 0.5× 79 1.7k
Fernando Caravaggio Canada 26 1.0k 1.2× 549 1.1× 628 1.6× 334 1.3× 144 0.6× 98 2.3k
David L. Garver United States 28 988 1.2× 591 1.2× 322 0.8× 430 1.6× 156 0.6× 82 2.3k
Gohei Yagi Japan 26 1.2k 1.4× 458 0.9× 142 0.4× 301 1.1× 183 0.7× 93 2.4k
Giovanni Muscettola Italy 26 562 0.7× 533 1.1× 224 0.6× 341 1.3× 129 0.5× 63 1.7k
Jeffrey M. Goldstein United States 24 782 0.9× 555 1.1× 161 0.4× 274 1.0× 120 0.5× 67 1.6k

Countries citing papers authored by Hugo A. Jørgensen

Since Specialization
Citations

This map shows the geographic impact of Hugo A. Jørgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo A. Jørgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo A. Jørgensen more than expected).

Fields of papers citing papers by Hugo A. Jørgensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugo A. Jørgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo A. Jørgensen. The network helps show where Hugo A. Jørgensen may publish in the future.

Co-authorship network of co-authors of Hugo A. Jørgensen

This figure shows the co-authorship network connecting the top 25 collaborators of Hugo A. Jørgensen. A scholar is included among the top collaborators of Hugo A. Jørgensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo A. Jørgensen. Hugo A. Jørgensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sinkeviciute, Igne, Rolf Gjestad, Kenneth Hugdahl, et al.. (2019). Trajectories of Treatment Response in Hallucinations. Neuropsychiatry. 9(1). 2 indexed citations
2.
Gjestad, Rolf, Igne Sinkeviciute, Rune A. Kroken, et al.. (2018). Trajectories of depressive symptoms in the acute phase of psychosis: Implications for treatment. Journal of Psychiatric Research. 103. 219–228. 5 indexed citations
3.
Gjestad, Rolf, et al.. (2016). Patient satisfaction after acute admission for psychosis. Nordic Journal of Psychiatry. 70(5). 321–328. 23 indexed citations
4.
Brønnick, Kolbjørn, et al.. (2016). The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement. PLoS ONE. 11(12). e0167390–e0167390. 16 indexed citations
5.
Johnsen, Erik, Igne Sinkeviciute, Else‐Marie Løberg, et al.. (2013). Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study. BMC Psychiatry. 13(1). 241–241. 12 indexed citations
6.
Johnsen, Erik, et al.. (2011). Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: A pragmatic, randomized trial. European Psychiatry. 28(3). 174–184. 21 indexed citations
7.
Jørgensen, Hugo A., et al.. (2011). Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial. BMC Psychiatry. 11(1). 145–145. 19 indexed citations
8.
Jørgensen, Hugo A., et al.. (2011). Admissions to a Norwegian emergency psychiatric ward: patient characteristics and referring agents. A prospective study. Nordic Journal of Psychiatry. 66(1). 40–48. 17 indexed citations
9.
Mehlum, Lars, et al.. (2010). Suicide Risk and Acute Psychiatric Readmissions: A Prospective Cohort Study. Psychiatric Services. 61(1). 25–31. 49 indexed citations
10.
Johnsen, Erik, Rune A. Kroken, Tore Wentzel‐Larsen, & Hugo A. Jørgensen. (2010). Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone. BMC Psychiatry. 10(1). 26–26. 46 indexed citations
11.
Jørgensen, Hugo A., et al.. (2009). A 1H-MR Spectroscopy Study of Changes in Glutamate and Glutamine (Glx) Concentrations in Frontal Spectra after Administration of Memantine. Cerebral Cortex. 20(4). 798–803. 32 indexed citations
12.
Johnsen, Erik, et al.. (2008). 316 – Antipsychotic-induced hyperprolactinemia: A cross-sectional survey. Schizophrenia Research. 98. 163–163. 4 indexed citations
13.
Andreassen, Ole A. & Hugo A. Jørgensen. (2000). Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Progress in Neurobiology. 61(5). 525–541. 184 indexed citations
14.
Jørgensen, Hugo A.. (1998). [Antipsychotic agents and adverse effects].. PubMed. 118(28). 4337–4337. 1 indexed citations
15.
Meshul, Charles K., Cynthia Allen, Ole A. Andreassen, & Hugo A. Jørgensen. (1996). Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol. Psychopharmacology. 125(3). 238–247. 39 indexed citations
16.
Andreassen, Ole A., Trond Oskar Aamo, & Hugo A. Jørgensen. (1996). Inhibition by memantine of the development of persistent oral dyskinesias induced by long‐term haloperidol treatment of rats. British Journal of Pharmacology. 119(4). 751–757. 36 indexed citations
17.
Andreassen, Ole A. & Hugo A. Jørgensen. (1995). The rat model of tardive dyskinesia: Relationship between vacuous chewing movements and gross motor activity during acute and long-term haloperidol treatment. Life Sciences. 57(24). 2263–2272. 17 indexed citations
18.
Andreassen, Ole A. & Hugo A. Jørgensen. (1994). GM1 ganglioside attenuates the development of vacuous chewing movements induced by long-term haloperidol treatment of rats. Psychopharmacology. 116(4). 517–522. 33 indexed citations
19.
Jørgensen, Hugo A., Ole A. Andreassen, & Kjell Hole. (1994). The relationship between motor effects in rats following acute and chronic haloperidol treatment. Psychopharmacology. 116(1). 89–92. 17 indexed citations
20.
Fasmer, Ole Bernt, et al.. (1987). Antinociceptive effects of (±)-, (+)- and (-)-nefopam in mice. Journal of Pharmacy and Pharmacology. 39(7). 508–511. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduard Parellada Breakdown of academic impact, for papers by Burt Angrist Breakdown of academic impact, for papers by Suzanne Reeves Breakdown of academic impact, for papers by Nobuhisa Kanahara Breakdown of academic impact, for papers by A. Klimke Breakdown of academic impact, for papers by Fernando Caravaggio Breakdown of academic impact, for papers by David L. Garver Breakdown of academic impact, for papers by Gohei Yagi Breakdown of academic impact, for papers by Giovanni Muscettola Breakdown of academic impact, for papers by Jeffrey M. Goldstein
Rankless by CCL
2026